MedTrace Logo

Spinal Analgesia in Labour Pain

NCT07332130 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-01-12

No results posted yet for this study

Summary

To evaluate the efficacy and safety of dexmedetomidine as an adjuvant to bupivacain and fentanyl in spinal Analgesia to decreases pain during normal labour

Conditions

  • Labour Analgesia

Interventions

DRUG

injecting dexmedetomidine

injecting dexmedetomidine intrathecally during labour pain

DRUG

injecting mixture of bupivacaine fentanyl

injecting mixture of bupivacaine fentanyl intrathecally

Sponsors & Collaborators

  • Minia University Hospital

    lead OTHER

Principal Investigators

  • Mohamed Ragab, master · Minia University Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-24
Primary Completion
2026-01-10
Completion
2026-03-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07332130 on ClinicalTrials.gov